Edwards Short Long Term Debt Total from 2010 to 2024

EW Stock  USD 72.07  0.52  0.73%   
Edwards Lifesciences Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total will likely drop to about 486.4 M in 2024. During the period from 2010 to 2024, Edwards Lifesciences Short and Long Term Debt Total regression line of quarterly data had mean square error of 40686.5 T and geometric mean of  541,111,250. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2000-03-31
Previous Quarter
693 M
Current Value
706.7 M
Quarterly Volatility
285.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.7 M, Interest Expense of 10.6 M or Selling General Administrative of 1.8 B, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 4.82. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
  
Check out the analysis of Edwards Lifesciences Correlation against competitors.

Latest Edwards Lifesciences' Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Edwards Lifesciences Corp over the last few years. It is Edwards Lifesciences' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edwards Lifesciences' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Edwards Short Long Term Debt Total Regression Statistics

Arithmetic Mean596,526,167
Geometric Mean541,111,250
Coefficient Of Variation37.32
Mean Deviation151,755,267
Median599,900,000
Standard Deviation222,612,325
Sample Variance49556.2T
Range886M
R-Value0.49
Mean Square Error40686.5T
R-Squared0.24
Significance0.07
Slope24,265,170
Total Sum of Squares693787.5T

Edwards Short Long Term Debt Total History

2024486.4 M
2022691.3 M
2021690.3 M
2020694.9 M
2019678.8 M
2018593.8 M
2017B

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total694.9 M486.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.